Health ❯Healthcare ❯Regulatory Affairs

Drug Approval

FDA FDA and EMA Perspectives European Medicines Agency MHRA NICE Guidelines Gilead Sciences Label Expansion European Union EMA EMA (European Medicines Agency)

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

Novo Nordisk's Oral Semaglutide Shows 14% Reduction in Heart Risks

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety

Weight-Loss Drugs Reshape Health and Consumer Markets